In coronary artery disease, drug eluting stents (DES) containing antiproliferative drugs such as the mTOR inhibitor Everolimus are successfully utilized to prevent restenosis by inhibiting intimal proliferation (51). This evidence concerns the gene MTOR and coronary artery disorder.